Physician

Ryan Fusato, M.D.

According to 2025 Medicare claims, Ryan Fusato, M.D. (NPI: 1578580296) practices internal medicine in the Kahului-Wailuku, HI market, with the plurality of this provider's patient population coming from Maui, HI. This provider's primary affiliated billing organization is MAUI MEDICAL GROUP INC (NPI: 1215963970; TIN: 990176859) and primary practice location at 96768-8544.

Fusato's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 460 traditional Medicare patients, billed 1,672 HCPCS/CPT codes, and received $76,636 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 10,357 prescription claims across 915 beneficiaries totaling $1,366,268 in drug costs, led by Ozempic (Semaglutide). DME data shows 33 claims. Open Payments data shows 2 records totaling $35. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $379,428 to $1,366,268. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,723 to $9,384.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	311	1,400	$76,140
2016	332	1,409	$77,468
2017	336	1,470	$78,853
2018	382	1,523	$70,288
2019	425	1,442	$65,476
2020	471	1,266	$60,499
2021	506	1,324	$91,006
2022	456	1,265	$75,270
2023	459	1,257	$65,725
2024	460	1,672	$76,636

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	409	5,322	$379,428
2016	428	5,921	$434,912
2017	516	6,990	$637,422
2018	591	7,691	$518,177
2019	716	8,567	$615,483
2020	841	9,311	$702,574
2021	786	8,083	$733,111
2022	789	9,579	$931,830
2023	857	9,795	$1,124,354
2024	915	10,357	$1,366,268

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	28	$421
2016	N/R	12	$3,161
2017	N/R	26	$10,348
2018	N/R	N/R	N/R
2019	N/R	11	$143
2020	N/R	15	$145
2021	N/R	N/R	N/R
2022	N/R	35	$766
2023	N/R	44	$1,096
2024	N/R	33	$2,717

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	405	701	$53
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	256	256	$53
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	74	104	$45
99441	Telephone medical discussion with physician, 5-10 minutes	26	27	$36
G0008	Administration of influenza virus vaccine	26	26	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	163	7,414	$233,813
Jardiance	Empagliflozin	80	5,585	$111,685
Ingrezza	Valbenazine Tosylate	12	360	$100,774
Eliquis	Apixaban	66	5,130	$96,610
Xarelto	Rivaroxaban	51	4,090	$73,207

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	19	$2,517
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	14	$200

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$35	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ryan Fusato, M.D.?

Tedicare shows public-source Medicare data for Ryan Fusato, M.D. (NPI 1578580296), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Fusato, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Fusato, M.D.?

Ryan Fusato, M.D. is linked to MAUI MEDICAL GROUP INC (billing NPI 1215963970) in the available physician profile data.

Does Ryan Fusato, M.D. have Open Payments data?

Ryan Fusato, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.